Skip to content
healthcare.dev
Get a free key

Doxorubicin Hydrochloride Liposome

NDC 25021-263, Doxorubicin Hydrochloride, injection, suspension, liposomal, from Sagent Pharmaceuticals.

Product NDC
25021-263
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219881
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-263 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
25021-263-10250210263101 VIAL in 1 CARTON (25021-263-10) / 10 mL in 1 VIAL
25021-263-25250210263251 VIAL in 1 CARTON (25021-263-25) / 25 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c8eb4784-36e0-483f-9e5d-af0552e49bb5

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-263

Use it

Look up 25021-263 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-263 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-263. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.